Business
Bicycle Therapeutics is a clinical-stage biotechnology company using Bicycle molecules, including Bicycle Drug Conjugates, for oncology and other disease areas.
Bicycle doubled collaboration revenue, but losses and free cash burn widened and insiders were sellers.
The read at a glance✓ Audited against SEC data
- Business mix — Clinical oncology Bicycle platformNote
- Revenue — Revenue rose 105.8%OK
- Losses — Net loss widened to $219.0MWatch
- Cash — Free cash flow fell to -$252.0MWatch
- Balance sheet — Equity fell 23.1%Watch
- Insiders — 0 purchases / 34 salesWatch
- Accounting — Altman-Z distress; other forensic fields unavailableWatch
Where the revenue comes from
Fiscal 2025, as BICYCLE THERAPEUTICS PLC reports it. History and quarterly detail are in the app.
- Single Reportable$72.6M
Leadership changes
From BICYCLE THERAPEUTICS PLC's own filings, the day they're filed.
- Consulting Period · departureeff. 2026-04-29
- Travis Thompson · Chief Financial Officer · appointmenteff. 2026-01-29
- Alethia Young · Chief Financial Officer · appointmenteff. 2026-01-29
Latest filings
- 8-K · Company announcement2026-08-20
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-06-18
- 8-K · Company announcement2026-05-21
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about BICYCLE THERAPEUTICS PLC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.